HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Muscle 3243A-->G mutation load and capacity of the mitochondrial energy-generating system.

AbstractOBJECTIVE:
The mitochondrial energy-generating system (MEGS) encompasses the mitochondrial enzymatic reactions from oxidation of pyruvate to the export of adenosine triphosphate. It is investigated in intact muscle mitochondria by measuring the pyruvate oxidation and adenosine triphosphate production rates, which we refer to as the "MEGS capacity." Currently, little is known about MEGS pathology in patients with mutations in the mitochondrial DNA. Because MEGS capacity is an indicator for the overall mitochondrial function related to energy production, we searched for a correlation between MEGS capacity and 3243A-->G mutation load in muscle of patients with the MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes) syndrome.
METHODS:
In muscle tissue of 24 patients with the 3243A-->G mutation, we investigated the MEGS capacity, the respiratory chain enzymatic activities, and the 3243A-->G mutation load. To exclude coinciding mutations, we sequenced all 22 mitochondrial transfer RNA genes in the patients, if possible.
RESULTS:
We found highly significant differences between patients and control subjects with respect to the MEGS capacity and complex I, III, and IV activities. MEGS-related measurements correlated considerably better with the mutation load than respiratory chain enzyme activities. We found no additional mutations in the mitochondrial transfer RNA genes of the patients.
INTERPRETATION:
The results show that MEGS capacity has a greater sensitivity than respiratory chain enzymatic activities for detection of subtle mitochondrial dysfunction. This is important in the workup of patients with rare or new mitochondrial DNA mutations, and with low mutation loads. In these cases we suggest to determine the MEGS capacity.
AuthorsAntoon J M Janssen, Markus Schuelke, Jan A M Smeitink, Frans J M Trijbels, Rob C A Sengers, Barbara Lucke, Liesbeth T M Wintjes, Eva Morava, Baziel G M van Engelen, Bart W Smits, Frans A Hol, Marloes H Siers, Henk Ter Laak, Marjo S van der Knaap, Francjan J Van Spronsen, Richard J T Rodenburg, Lambert P van den Heuvel
JournalAnnals of neurology (Ann Neurol) Vol. 63 Issue 4 Pg. 473-81 (Apr 2008) ISSN: 1531-8249 [Electronic] United States
PMID18306232 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA, Mitochondrial
  • Guanine
  • Adenosine
Topics
  • Adenosine (genetics)
  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • DNA, Mitochondrial (genetics, metabolism)
  • Electron Transport (genetics)
  • Energy Metabolism (genetics)
  • Female
  • Guanine (physiology)
  • Humans
  • Infant
  • MELAS Syndrome (diagnosis, genetics, metabolism)
  • Male
  • Middle Aged
  • Mitochondria, Muscle (genetics, metabolism)
  • Muscle, Skeletal (pathology, physiology)
  • Mutation (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: